Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Does melatonin improve the tolerability of chemotherapy?

June 24, 1999

Cell Pathways completes phase III APC trial analysis

June 24, 1999

U.K. is first market for new formulation of Casodex

June 23, 1999

Anti-VEGF antibody reverses ascites associated with ovarian cancer in rodent model

June 22, 1999

Sustained-release formulation of GnRH antagonist assessed for PD/PK in dogs

June 21, 1999

Lead GnRH antagonist presented at Endocrine Society meeting by Abbott, TAP

June 21, 1999

New paclitaxel derivatives with broad anticancer activity developed at Xechem

June 21, 1999

Orally active GnRH antagonist evaluated in preclinical models by Abbott investigators

June 18, 1999

A-198401: another compound emerges from Abbott's focus on nonpeptide GnRH antagonists

June 18, 1999

Ono claims new series of matrix metalloproteinase inhibitors

June 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.